HR 1193 RDS
‘‘(3) Corroborating data generated through clin-
ical trials to develop a prediction model to distin-
guish individuals at high risk for sudden cardiac ar-
rest or sudden cardiac death from valvular heart dis-
ease. 
‘‘(4) For other outcomes needed to acquire nec-
essary data on valvular heart disease. 
‘‘(c) MITRAL VALVE PROLAPSE WORKSHOP.—Not 
later than one year after the date of the enactment of this 
section, the Director of the Institute shall convene a work-
shop composed of subject matter experts and stakeholders 
to identify research needs and opportunities to develop 
prescriptive guidelines for treatment of individuals with 
mitral valve prolapse. 
‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there is authorized 
to be appropriated $20,000,000 for each of fiscal years 
2022 through 2026.’’. 
SEC. 3. PROGRAMS OF CENTERS FOR DISEASE CONTROL 
AND PREVENTION. 
Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.) is amended by inserting after sec-
tion 312 the following section: 
VerDate Sep 11 2014 
02:05 Feb 08, 2022
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H1193.RDS
H1193
kjohnson on DSK79L0C42PROD with BILLS
HR 1193 RDS
‘‘SEC. 312A. PREVENTION OF SUDDEN CARDIAC DEATH AS A 
RESULT OF VALVULAR HEART DISEASE. 
‘‘(a) IN GENERAL.—The Secretary, acting through 
the Director of the Centers for Disease Control and Pre-
vention, may carry out projects to increase education, 
awareness, or diagnosis of valvular heart disease and to 
reduce the incidence of sudden cardiac death caused by 
valvular heart disease. Such projects may be carried out 
by the Secretary directly or through awards of grants or 
contracts to public or nonprofit private entities. The Sec-
retary may directly (or through such awards) provide tech-
nical assistance with respect to the planning, development, 
and operation of such projects. 
‘‘(b) CERTAIN ACTIVITIES.—Upon availability of ap-
plicable data, projects carried out under subsection (a) 
may include— 
‘‘(1) continuing the activities at the Division for 
Heart Disease and Stroke Prevention, including 
those related to valvular heart disease; 
‘‘(2) broadening the awareness of the public 
concerning the risk factors for, the symptoms of, 
and the public health consequences of valvular heart 
disease; and 
‘‘(3) enhancing surveillance of out-of-hospital 
cardiac arrests to improve patient outcomes. 
VerDate Sep 11 2014 
02:05 Feb 08, 2022
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1193.RDS
H1193
kjohnson on DSK79L0C42PROD with BILLS
HR 1193 RDS
‘‘(c) GRANT PRIORITIZATION.—The Secretary may, 
in awarding grants or entering into contracts pursuant to 
subsection (a), give priority to entities seeking to carry 
out projects that target populations most impacted by val-
vular heart disease. 
‘‘(d) COORDINATION OF ACTIVITIES.—The Secretary 
shall ensure that activities under this section are coordi-
nated, as appropriate, with other agencies of the Public 
Health Service that carry out activities regarding valvular 
heart disease. 
‘‘(e) BEST
PRACTICES.—The Secretary, acting 
through the Director of the Centers for Disease Control 
and Prevention, shall— 
‘‘(1) collect and analyze the findings of research 
conducted with respect to valvular heart disease; and 
‘‘(2) taking into account such findings, publish 
on the website of the Centers for Disease Control 
and Prevention best practices for physicians and 
other health care providers who provide care to indi-
viduals with valvular heart disease.’’. 
Passed the House of Representatives December 8, 
2021. 
Attest: 
CHERYL L. JOHNSON, 
Clerk. 
VerDate Sep 11 2014 
02:05 Feb 08, 2022
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H1193.RDS
H1193
kjohnson on DSK79L0C42PROD with BILLS